Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06521554
Title A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nuvalent Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute RECRUITING Stanford California 94305 United States Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Henry Ford Cancer Center RECRUITING Detroit Michigan 48242 United States Details
Washington University RECRUITING Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field